{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:30:56Z","timestamp":1777631456222,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["17K09009"],"award-info":[{"award-number":["17K09009"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s12185-020-02874-1","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T10:02:46Z","timestamp":1586167366000},"page":"96-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Acquired dysfibrinogenemia: monoclonal \u03bb-type IgA binding to fibrinogen caused lower functional plasma fibrinogen level and abnormal clot formation"],"prefix":"10.1007","volume":"112","author":[{"given":"Shinpei","family":"Arai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomu","family":"Kamijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Takezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutoshi","family":"Sugano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryu","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"key":"2874_CR1","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","volume":"3","author":"MW Mosesson","year":"2005","unstructured":"Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3:1894\u2013904.","journal-title":"J Thromb Haemost"},{"key":"2874_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/MOH.0b013e3280dce58c","volume":"14","author":"ST Lord","year":"2007","unstructured":"Lord ST. Fibrinogen and fibrin: scaffold proteins in hemostasis. Curr Opin Hematol. 2007;14:236\u201341.","journal-title":"Curr Opin Hematol"},{"key":"2874_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1055\/s-0033-1349222","volume":"39","author":"P De Moerloose","year":"2013","unstructured":"De Moerloose P, Casini A, Neerman-Arbez M. Congenital fibrinogen disorders: an update. Semin Thromb Hemost. 2013;39:585\u201395.","journal-title":"Semin Thromb Hemost"},{"key":"2874_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/jth.12916","volume":"13","author":"A Casini","year":"2015","unstructured":"Casini A, Neerman-Arbez M, Ari\u00ebns RA, De Moerloose P. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management. J Thromb Haemost. 2015;13:909\u201319.","journal-title":"J Thromb Haemost"},{"key":"2874_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0049-3848(87)90272-6","volume":"46","author":"E Rega\u00f1\u00f3n","year":"1987","unstructured":"Rega\u00f1\u00f3n E, Vila V, Aznar J, Garrido G, Estell\u00e9s A, Berenguer J. Study of the formation of fibrin clot in cirrhotic patients. An approach to study of acquired dysfibrinogenemia. Thromb Res. 1987;46:705\u201314.","journal-title":"Thromb Res"},{"key":"2874_CR6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/jcp.35.6.667","volume":"35","author":"JL Francis","year":"1982","unstructured":"Francis JL, Armstrong DJ. Acquired dysfibrinogenaemia in liver disease. J Clin Pathol. 1982;35:667\u201372.","journal-title":"J Clin Pathol"},{"key":"2874_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1749-6632.1983.tb23259.x","volume":"408","author":"J Martinez","year":"1983","unstructured":"Martinez J, Keane PM, Gilman PB, Palascak JE. The abnormal carbohydrate composition of the dysfibrinogenemia associated with liver disease. Ann NY Acad Sci. 1983;408:388\u201396.","journal-title":"Ann NY Acad Sci"},{"key":"2874_CR8","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1097\/00005176-198711000-00025","volume":"6","author":"J Levy","year":"1987","unstructured":"Levy J, Pettei MJ, Weitz JI. Dysfibrinogenemia in obstructive liver disease. J Pediatr Gastroenterol Nutr. 1987;6:967\u201370.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2874_CR9","first-page":"1195","volume":"266","author":"ME Carr Jr","year":"1994","unstructured":"Carr ME Jr, Zekert SL. Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma. Am J Physiol. 1994;266:1195\u2013201.","journal-title":"Am J Physiol"},{"key":"2874_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000205551","volume":"81","author":"T Shigekiyo","year":"1989","unstructured":"Shigekiyo T, Kosaka M, Shintani Y, Azuma H, Iishi Y, Saito S. Inhibition of fibrin monomer polymerization by Bence Jones protein in a patient with primary amyloidosis. Acta Haematol. 1989;81:160\u20135.","journal-title":"Acta Haematol"},{"key":"2874_CR11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/0002-9343(85)90414-0","volume":"78","author":"NA Dawson","year":"1985","unstructured":"Dawson NA, Barr CF, Alving BM. Acquired dysfibrinogenemia. Paraneoplastic syndrome in renal cell carcinoma. Am J Med. 1985;78:682\u20136.","journal-title":"Am J Med"},{"key":"2874_CR12","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ibd.21334","volume":"17","author":"NL Zitomersky","year":"2011","unstructured":"Zitomersky NL, Verhave M, Trenor CC. Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention. Inflamm Bowel Dis. 2011;17:458\u201370.","journal-title":"Inflamm Bowel Dis"},{"key":"2874_CR13","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1172\/JCI113704","volume":"82","author":"A Ruiz-Arguelles","year":"1988","unstructured":"Ruiz-Arguelles A. Spontaneous reversal of acquired autoimmune dysfibrinogenemia probably due to an antiidiotypic antibody directed to an interspecies cross-reactive idiotype expressed on antifibrinogen antibodies. J Clin Invest. 1988;82:958\u201363.","journal-title":"J Clin Invest"},{"key":"2874_CR14","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1182\/blood.V52.5.1037.1037","volume":"52","author":"DK Galanakis","year":"1978","unstructured":"Galanakis DK, Ginzler EM, Fikrig SM. Monoclonal IgG anticoagulants delaying fibrin aggregation in two patients with systemic lupus erythematosus (SLE). Blood. 1978;52:1037\u201346.","journal-title":"Blood"},{"key":"2874_CR15","first-page":"436","volume":"39","author":"Y Ozaki","year":"1998","unstructured":"Ozaki Y, Kagawa H, Yasuzawa M, Yoshimura C, Shimizu T, Nomura S, et al. Anti-fibrinogen antibody detected in a patient with systemic lupus erythematosus and disseminated intravascular coagulation. Rinsho Ketsueki. 1998;39:436\u201341.","journal-title":"Rinsho Ketsueki"},{"key":"2874_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00000441-198607000-00011","volume":"292","author":"MA Ashby","year":"1986","unstructured":"Ashby MA, Lazarchick J. Acquired dysfibrinogenemia secondary to mithramycin toxicity. Am J Med Sci. 1986;292:53\u20135.","journal-title":"Am J Med Sci"},{"key":"2874_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1182\/blood.V39.2.224.224","volume":"39","author":"S Sugai","year":"1972","unstructured":"Sugai S. IgA pyroglobulin, hyperviscosity syndrome and coagulation abnormality in a patient with multiple myeloma. Blood. 1972;39:224\u201337.","journal-title":"Blood"},{"key":"2874_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/jcp.47.3.266","volume":"47","author":"MJ O'Kane","year":"1994","unstructured":"O'Kane MJ, Wisdom GB, Desai ZR, Archbold GP. Inhibition of fibrin monomer polymerisation by myeloma immunoglobulin. J Clin Pathol. 1994;47:266\u20138.","journal-title":"J Clin Pathol"},{"key":"2874_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000160182","volume":"120","author":"R Kotl\u00edn","year":"2008","unstructured":"Kotl\u00edn R, Sobotkov\u00e1 A, Riedel T, Salaj P, Suttnar J, Reicheltov\u00e1 Z, et al. Acquired dysfibrinogenemia secondary to multiple myeloma. Acta Haematol. 2008;120:75\u201381.","journal-title":"Acta Haematol"},{"key":"2874_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3324\/haematol.11837","volume":"92","author":"A Dear","year":"2007","unstructured":"Dear A, Brennan SO, Sheat MJ, Faed JM, George PM. Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin lambda light chain. Haematologica. 2007;92:111\u20137.","journal-title":"Haematologica"},{"key":"2874_CR21","first-page":"449","volume":"67","author":"S Arai","year":"2019","unstructured":"Arai S, Kamijo T, Takezawa Y, Sugano M, Uehara T, Honda T, et al. Analysis of a false low value for fibrinogen activity and abnormal clot waveform in a patient with IgA M-protein. Rinsho Byori. 2019;67:449\u201356.","journal-title":"Rinsho Byori"},{"key":"2874_CR22","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538\u2013e548548.","journal-title":"Lancet Oncol"},{"key":"2874_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.thromres.2016.11.002","volume":"148","author":"S Mukai","year":"2016","unstructured":"Mukai S, Nagata K, Ikeda M, Arai S, Sugano M, Honda T, et al. Genetic analyses of novel compound heterozygous hypodysfibrinogenemia, Tsukuba I: FGG c.1129+62_65 del AATA and FGG c.1299+4 del A. Thromb Res. 2016;148:111\u20137.","journal-title":"Thromb Res"},{"key":"2874_CR24","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1182\/blood.V94.12.4122","volume":"94","author":"F Terasawa","year":"1999","unstructured":"Terasawa F, Okumura N, Kitano K, Hayashida N, Shimosaka M, Okazaki M, et al. Hypofibrinogenemia associated with a heterozygous missense mutation gamma153Cys to Arg (Matsumoto IV): in vitro expression demonstrates defective secretion of the variant fibrinogen. Blood. 1999;94:4122\u201331.","journal-title":"Blood"},{"key":"2874_CR25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1055\/s-0038-1653837","volume":"73","author":"M Takebe","year":"1995","unstructured":"Takebe M, Soe G, Kohno I, Sugo T, Matsuda M. Calcium ion-dependent monoclonal antibody against human fibrinogen: preparation, characterization, and application to fibrinogen purification. Thromb Haemost. 1995;73:662\u20137.","journal-title":"Thromb Haemost"},{"key":"2874_CR26","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.thromres.2014.06.002","volume":"134","author":"M Ikeda","year":"2014","unstructured":"Ikeda M, Kobayashi T, Arai S, Mukai S, Takezawa Y, Terasawa F, et al. Recombinant \u03b3T305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites. Thromb Res. 2014;134:518\u201325.","journal-title":"Thromb Res"},{"key":"2874_CR27","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/MBC.0b013e328332aa09","volume":"20","author":"Y Kamijyo","year":"2009","unstructured":"Kamijyo Y, Hirota-Kawadobora M, Yamauchi K, Terasawa F, Honda T, Ikeya M, et al. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II). Blood Coagul Fibrinolysis. 2009;20:726\u201332.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2874_CR28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.thromres.2015.01.013","volume":"135","author":"M Ikeda","year":"2015","unstructured":"Ikeda M, Arai S, Mukai S, Takezawa Y, Terasawa F, Okumura N. Novel heterozygous dysfibrinogenemia, Sumida (A\u03b1C472S), showed markedly impaired lateral aggregation of protofibrils and mildly lower functional fibrinogen levels. Thromb Res. 2015;135:710\u20137.","journal-title":"Thromb Res"},{"key":"2874_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/scientificamerican1281-126","volume":"245","author":"RF Doolittle","year":"1981","unstructured":"Doolittle RF. Fibrinogen and fibrin. Sci Amer. 1981;245:126\u201335.","journal-title":"Sci Amer"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02874-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-020-02874-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02874-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:17:43Z","timestamp":1617668263000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-020-02874-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["2874"],"URL":"https:\/\/doi.org\/10.1007\/s12185-020-02874-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,6]]},"assertion":[{"value":"5 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}